搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
ALS News Today
5 小时
Caregiving for my late husband often left me feeling helpless
Although she did everything possible to learn about ALS, columnist Juliet Taylor says the disease often left her feeling ...
ALS News Today
6 小时
ALS Association funds small clinical trial of intranasal foralumab in ALS
A grant from the ALS Association will fund an early-stage clinical trial to test Tiziana's foralumab nasal spray in 20 ALS ...
ALS News Today
1 天
Largest ALS patient-based stem cell, biodata resource opens for research
The world's largest ALS patient-derived stem cell and biodata repository is now available to researchers globally.
ALS News Today
2 天
First-in-human trial of ALS therapy ASHA-624 expected in early 2025
A newly awarded grant from the ALS Association will support Asha Therapeutics' work to advance ASHA-624 into a first-in-human ...
ALS News Today
2 天
What I do when I’m feeling unmotivated in life with ALS
Lately columnist Dagmar Munn has been feeling unmotivated and exhausted, but she has several strategies that help her get out ...
ALS News Today
1 天
A do-it-yourself approach to mental health while caregiving
I’m a do-it-yourself kind of gal. This has served my husband, Todd, and I well over the last 14 years as I’ve been his primary caregiver. We do not have an ALS clinic near our home, and our local ...
ALS News Today
3 天
EMA recommends NUZ-001 for orphan drug status in Europe
The EMA recommended that NUZ-001, formerly monepantel, be granted orphan medicinal product designation to treat ALS in Europe ...
ALS News Today
4 天
Phase 2 trial of ROCK inhibitor Bravyl now fully enrolled
A Phase 2 trial testing oral ROCK inhibitor Bravyl in people with ALS is now fully enrolled at its highest dosing group.
ALS News Today
7 天
Biopharmaceutical launches with goal to develop treatment for ALS
Trace Neuroscience has launched in the U.S. with over $100 million in financing and a goal to develop its UNC13A-targeted ...
ALS News Today
9 天
Kadimastem, NLS merge to advance ALS therapy AstroRx, other drugs
The newly combined company will focus on moving Kadimastem's AstroRx, NLS's DOXA platform, and other therapies through ...
ALS News Today
8 天
Research grant provides $7.3M for NU-9 development
The National Institute of Aging awarded a $7.3 million research grant for the study of NU-9 as a treatment for ...
ALS News Today
10 天
Mitochondrial genome mutations linked to ALS in genetic study
Mitochondrial genome mutations may be linked to ALS, per a study, opening the door for new ways to diagnosing and treating ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈